Target intelligence / Profile preview

Solute carrier family 25 member 53 (SLC25A53)

Target
SLC25A53
Molecular classification
Transporter, Mitochondrial carrier family (SLC25), Multi-pass membrane protein
01

Overview

Solute carrier family 25 member 53 (SLC25A53) is a mitochondrial inner membrane transporter that belongs to the SLC25 family of mitochondrial carrier proteins, which are responsible for transporting a variety of metabolites, nucleotides, and cofactors between the cytosol and the mitochondrial matrix[1][2][4][6][8]. SLC25A53 is classified as an orphan transporter, meaning its precise physiological substrates are not definitively identified, although it is predicted to participate in NAD transmembrane transport[5]. It is expressed in mitochondria as a multi-pass membrane protein[1]. Genetic associations suggest possible links to progressive external ophthalmoplegia and spastic paraplegia[5]. No direct drug interactors or validated roles as a drug target have been described in the current literature and drug databases[5][7]. As a member of the mitochondrial carrier family, SLC25A53 may play roles in energy metabolism and mitochondrial maintenance, but most of its biological and clinical roles remain to be clarified[1][2][5].

Other names
MCART6Mitochondrial carrier triple repeat protein 6S2553_HUMANsolute carrier family 25, member 53
02

Biological functions

Mitochondrial transportLikely NAD transmembrane transport (predicted)Cellular metabolismEnergy homeostasis
03

Disease associations

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2Spastic paraplegia 9A, autosomal dominantOther (potential involvement in mitochondrial diseases)

Beyond the preview

Go deeper on Solute carrier family 25 member 53 (SLC25A53).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 53 (SLC25A53).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call